PT Indofarma Tbk (IDX:INAF)

Indonesia · Delayed Price · Currency is IDR

126.00

0.00 (0.00%)

Jul 1, 2024, 2:55 PM WIB

-80.00% (1Y)

Market Cap	390.51B -81.2%
Revenue (ttm)	151.55B -28.0%
Net Income	-77.99B
EPS	-25.16
Shares Out	3.10B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	126.00
Day's Range	126.00 - 126.00
52-Week Range	126.00 - 725.00
Beta	0.29
Analysts	n/a
Price Target	517.50 (+310.71%)
Earnings Date	Jul 31, 2026

About PT Indofarma Tbk

PT Indofarma Tbk, together with its subsidiaries, manufactures and sells pharmaceutical products in Indonesia and internationally. The company operates through medicine, Medical devices and Others, and Engineering Pharmaceuticals. It engages in marketing, trading and distribution of medicine and medical devices; and clinical lab. The company was formerly known as PT Indofarma (Persero) Tbk. PT Indofarma Tbk was founded in 1918 and is based in Bekasi, Indonesia. The company operates as a subsidiary of PT Bio Farma. [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1918

Employees 44

Stock Exchange Indonesia Stock Exchange

Ticker Symbol INAF

Full Company Profile

Financial Performance

In 2025, PT Indofarma Tbk's revenue was 151.55 billion, a decrease of -27.96% compared to the previous year's 210.38 billion. Losses were -77.99 billion, -76.68% less than in 2024.

Financial Statements